LY3002813-IV for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Apr 2013: Trial registered, NCT01837641
  2. 3 May 2013: Trial started, NCT01837641

The trials

NCT01837641: A Study of LY3002813 in Participants With Alzheimer's Disease

State
Completed
Phase
Phase 1
People
63 taking part
Started
3 May 2013
Primary completion
24 Aug 2016
Arms
LY3002813-Single 0.1 mg/kg then multiple 0.3 mg/kg, LY3002813-Single then multiple 0.3 mg/kg, LY3002813-Single 1 mg/kg in Healthy Participants, LY3002813-Single then multiple 1 mg/kg, LY3002813-Single then multiple 3 mg/kg, LY3002813-Single then multiple 10 mg/kg, LY3002813-IV
Results
Posted on the registry
  1. 23 Apr 2013: Trial registered
  2. 3 May 2013: Trial started
  3. 24 Aug 2016: Trial completed
  4. 4 Oct 2024: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.